Surfacide has introduced a new UV-C hard surface disinfection system for healthcare providers. The Helios system uses three light-emitting towers in the patient environment to eradicate drug-resistant organisms, including: C. Diff, MRSA, VRE, CRE and Acinetobacter. The Helios system is faster and more effective than single emitters because the three-piece system covers an entire room, including the bathroom and other hard to reach areas. In addition, the Helios emitters are positioned closer to hard surfaces, which cuts down cleaning time and improves overall efficacy.
“UV-C disinfection is one of the most effective tools to combat healthcare-associated infections,” said Gunner Lyslo, president of Surfacide. “However, the eradication of drug-resistant organisms begins to diminish the further a UV-C emitter is positioned from hard surfaces. Single emitters may leave areas untreated and require more disinfection time, while the Surfacide Helios system can clean an entire room in as little as 30 minutes.”
To operate the Surfacide Helios system, three articulating UV-C towers are wheeled into a patient room and positioned approximately 1.5-meters away from any surface. Each tower comes equipped with laser validation to ensure the room is completely covered during the disinfection process. Once validation is completed, the towers are activated. The disinfection process – which lasts roughly 30 minutes – reduces drug-resistant organisms found on hard surfaces such as, C. Diff, MRSA, VRE, CRE and Acinetobacter. This process significantly reduces the risk of HAIs, which are a major threat to hospitals, outpatient clinics, long-term care facilities and other healthcare environments.
The Surfacide Helios UV-C hard surface disinfection system is available in the U.S. and European markets.
For more information about the product, visit Surfacide.com or call 844-390-3538.
